JP2008519763A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008519763A5 JP2008519763A5 JP2007540158A JP2007540158A JP2008519763A5 JP 2008519763 A5 JP2008519763 A5 JP 2008519763A5 JP 2007540158 A JP2007540158 A JP 2007540158A JP 2007540158 A JP2007540158 A JP 2007540158A JP 2008519763 A5 JP2008519763 A5 JP 2008519763A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- linear
- compound
- formula
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 40
- 150000001875 compounds Chemical class 0.000 claims 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 9
- 206010030113 Oedema Diseases 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 7
- -1 cyclic ester Chemical class 0.000 claims 7
- 230000002207 retinal effect Effects 0.000 claims 6
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 125000000304 alkynyl group Chemical group 0.000 claims 4
- 208000035475 disorder Diseases 0.000 claims 4
- 230000002062 proliferating effect Effects 0.000 claims 4
- 206010012689 Diabetic retinopathy Diseases 0.000 claims 3
- 206010029113 Neovascularisation Diseases 0.000 claims 3
- 208000000208 Wet Macular Degeneration Diseases 0.000 claims 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 3
- 239000002775 capsule Substances 0.000 claims 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 3
- 150000001734 carboxylic acid salts Chemical class 0.000 claims 3
- 150000002596 lactones Chemical class 0.000 claims 3
- 206010062198 microangiopathy Diseases 0.000 claims 3
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 229910052744 lithium Inorganic materials 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000022873 Ocular disease Diseases 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 206010003246 arthritis Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 238000007887 coronary angioplasty Methods 0.000 claims 1
- 150000005676 cyclic carbonates Chemical class 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000011325 dry age related macular degeneration Diseases 0.000 claims 1
- 239000003885 eye ointment Substances 0.000 claims 1
- 229940069265 ophthalmic ointment Drugs 0.000 claims 1
- 208000037803 restenosis Diseases 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62620904P | 2004-11-09 | 2004-11-09 | |
| PCT/US2005/040392 WO2006052950A1 (en) | 2004-11-09 | 2005-11-08 | 5,6,7-trihydroxyheptanoic acid and analogs for the treatment of ocular diseases and diseases associated with hyperproliferative and angiogenic responses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012054606A Division JP2012107073A (ja) | 2004-11-09 | 2012-03-12 | 眼の疾患、ならびに増殖および脈管形成応答に関連する疾患の処置に関する５，６，７−トリヒドロキシヘプタン酸およびアナログ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008519763A JP2008519763A (ja) | 2008-06-12 |
| JP2008519763A5 true JP2008519763A5 (https=) | 2008-12-04 |
Family
ID=35809550
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007540158A Pending JP2008519763A (ja) | 2004-11-09 | 2005-11-08 | 眼の疾患、ならびに増殖および脈管形成応答に関連する疾患の処置に関する５，６，７−トリヒドロキシヘプタン酸およびアナログ |
| JP2012054606A Pending JP2012107073A (ja) | 2004-11-09 | 2012-03-12 | 眼の疾患、ならびに増殖および脈管形成応答に関連する疾患の処置に関する５，６，７−トリヒドロキシヘプタン酸およびアナログ |
| JP2014151656A Pending JP2014198730A (ja) | 2004-11-09 | 2014-07-25 | 眼の疾患、ならびに増殖および脈管形成応答に関連する疾患の処置に関する５，６，７−トリヒドロキシヘプタン酸およびアナログ |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012054606A Pending JP2012107073A (ja) | 2004-11-09 | 2012-03-12 | 眼の疾患、ならびに増殖および脈管形成応答に関連する疾患の処置に関する５，６，７−トリヒドロキシヘプタン酸およびアナログ |
| JP2014151656A Pending JP2014198730A (ja) | 2004-11-09 | 2014-07-25 | 眼の疾患、ならびに増殖および脈管形成応答に関連する疾患の処置に関する５，６，７−トリヒドロキシヘプタン酸およびアナログ |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US7879905B2 (https=) |
| EP (1) | EP1809270B1 (https=) |
| JP (3) | JP2008519763A (https=) |
| KR (1) | KR101237534B1 (https=) |
| CN (1) | CN101052387A (https=) |
| AT (1) | ATE461696T1 (https=) |
| AU (1) | AU2005304733B2 (https=) |
| BR (1) | BRPI0517972A (https=) |
| CA (1) | CA2584286C (https=) |
| CY (1) | CY1110644T1 (https=) |
| DE (1) | DE602005020178D1 (https=) |
| DK (1) | DK1809270T3 (https=) |
| ES (1) | ES2340786T3 (https=) |
| MX (1) | MX2007004622A (https=) |
| PL (1) | PL1809270T3 (https=) |
| PT (1) | PT1809270E (https=) |
| SI (1) | SI1809270T1 (https=) |
| WO (1) | WO2006052950A1 (https=) |
| ZA (1) | ZA200703992B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1809270T3 (pl) * | 2004-11-09 | 2010-08-31 | Alcon Inc | Kwas 5,6,7-trihydroksyheptanowy i jego analogi do leczenia chorób oczu i chorób związanych z odpowiedziami hiperproliferacyjnymi i angiogenicznymi |
| US20060154981A1 (en) * | 2005-01-12 | 2006-07-13 | Alcon, Inc. | Method of reducing intraocular pressure and treating glaucoma |
| US7687539B1 (en) | 2005-11-07 | 2010-03-30 | Alcon Research, Ltd. | Method of treating ocular allergy |
| MX2009004962A (es) * | 2006-11-07 | 2009-05-21 | Alcon Res Ltd | Metodo para tratar asma, rinitis alergia y trastornos de la piel. |
| CA2781309A1 (en) * | 2009-12-04 | 2011-06-09 | Euclid Systems Corporation | Composition and methods for the prevention and treatment of macular degeneration, diabetic retinopathy, and diabetic macular edema |
| WO2011096941A1 (en) * | 2010-02-08 | 2011-08-11 | Alcon Research, Ltd. | Method of treating ocular allergy |
| WO2011106599A1 (en) * | 2010-02-25 | 2011-09-01 | Alcon Research, Ltd. | Method of accelerating corneal wound healing |
| US11491006B2 (en) | 2019-04-10 | 2022-11-08 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4975537A (en) | 1985-10-23 | 1990-12-04 | The Upjohn Company | Δ9(11) -angiostatic steroids |
| US4771042A (en) | 1985-11-25 | 1988-09-13 | The Upjohn Company | Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments |
| JP2834512B2 (ja) * | 1990-01-30 | 1998-12-09 | 帝人株式会社 | リポキシン誘導体を有効成分とする疾患治療剤 |
| US5441951A (en) | 1994-06-15 | 1995-08-15 | Brigham & Women's Hospital | Lipoxin compounds |
| US6048897A (en) * | 1993-06-15 | 2000-04-11 | Brigham And Women's Hospital | Lipoxin compounds and their use in treating cell proliferative disorders |
| JPH08268886A (ja) | 1995-03-31 | 1996-10-15 | Eisai Co Ltd | 血管新生抑制剤 |
| ATE258791T1 (de) * | 1999-11-09 | 2004-02-15 | Alcon Inc | Lipoxin-a4 und deren analoge zur behandlung von trockenen augen |
| AR030345A1 (es) | 2000-08-14 | 2003-08-20 | Alcon Inc | Metodo de tratamiento de desordenes relacionados con angiogenesis |
| WO2002070068A2 (en) * | 2001-03-02 | 2002-09-12 | The Brigham And Women's Hospital | Lipoxin analogs as novel inhibitors of angiogenesis |
| DE602005017762D1 (de) | 2004-05-14 | 2009-12-31 | Alcon Inc | Methode zur behandlung trockener augen und uveitis |
| PL1809270T3 (pl) * | 2004-11-09 | 2010-08-31 | Alcon Inc | Kwas 5,6,7-trihydroksyheptanowy i jego analogi do leczenia chorób oczu i chorób związanych z odpowiedziami hiperproliferacyjnymi i angiogenicznymi |
-
2005
- 2005-11-08 PL PL05824279T patent/PL1809270T3/pl unknown
- 2005-11-08 DK DK05824279.3T patent/DK1809270T3/da active
- 2005-11-08 BR BRPI0517972-6A patent/BRPI0517972A/pt not_active IP Right Cessation
- 2005-11-08 CA CA2584286A patent/CA2584286C/en not_active Expired - Fee Related
- 2005-11-08 KR KR1020077010194A patent/KR101237534B1/ko not_active Expired - Fee Related
- 2005-11-08 DE DE602005020178T patent/DE602005020178D1/de not_active Expired - Lifetime
- 2005-11-08 MX MX2007004622A patent/MX2007004622A/es active IP Right Grant
- 2005-11-08 PT PT05824279T patent/PT1809270E/pt unknown
- 2005-11-08 US US11/268,968 patent/US7879905B2/en not_active Expired - Fee Related
- 2005-11-08 WO PCT/US2005/040392 patent/WO2006052950A1/en not_active Ceased
- 2005-11-08 SI SI200530999T patent/SI1809270T1/sl unknown
- 2005-11-08 JP JP2007540158A patent/JP2008519763A/ja active Pending
- 2005-11-08 ES ES05824279T patent/ES2340786T3/es not_active Expired - Lifetime
- 2005-11-08 AT AT05824279T patent/ATE461696T1/de active
- 2005-11-08 CN CNA200580037399XA patent/CN101052387A/zh active Pending
- 2005-11-08 AU AU2005304733A patent/AU2005304733B2/en not_active Ceased
- 2005-11-08 EP EP05824279A patent/EP1809270B1/en not_active Expired - Lifetime
- 2005-11-08 ZA ZA200703992A patent/ZA200703992B/xx unknown
-
2010
- 2010-05-28 CY CY20101100473T patent/CY1110644T1/el unknown
- 2010-12-14 US US12/967,141 patent/US20110082200A1/en not_active Abandoned
-
2012
- 2012-03-12 JP JP2012054606A patent/JP2012107073A/ja active Pending
-
2014
- 2014-07-25 JP JP2014151656A patent/JP2014198730A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2651162T3 (es) | Antagonistas fluorados de integrina | |
| AU2022256216B2 (en) | Antimicrobial compounds, compositions, and uses thereof | |
| JP6430670B2 (ja) | アルドース還元酵素阻害剤および同使用方法 | |
| ES2966094T3 (es) | Compuestos 4-oxo-3,4-dihidrotieno[3,4-d]piridazina como inhibidores de la aldosa reductasa y métodos de uso de los mismos | |
| JP6261011B2 (ja) | 眼疾患処置薬 | |
| JP2007518738A5 (https=) | ||
| JP2009537550A5 (https=) | ||
| JP2014508804A5 (https=) | ||
| ES2997117T3 (en) | Substituted pyrazolo piperidine carboxylic acids | |
| US20230130766A1 (en) | Mono and combination therapies with ulk1/2 inhibitors | |
| JP2013519653A5 (https=) | ||
| JP2013518036A5 (https=) | ||
| JP2008519763A5 (https=) | ||
| JP2016028032A5 (https=) | ||
| US20240391944A1 (en) | Antimicrobial compounds, compositions, and uses thereof | |
| RU2002130247A (ru) | Производные оксадиазола, обладающие противоопухолевым действием | |
| RU2459824C2 (ru) | Новые соединения для лечения психических расстройств, их получение и применение | |
| WO2024226869A1 (en) | Substituted pyrimidinedione compounds, compositions, and uses thereof | |
| JP2010509240A5 (https=) | ||
| JP2008508222A (ja) | ２−アミノ−１，３−プロパンジオール化合物およびその類似体の製剤 | |
| CN106279138B (zh) | 芳杂环类衍生物及其在药物中的应用 | |
| US9044464B2 (en) | No-releasing guanidine-coxib anti-cancer agents | |
| JP2007537282A5 (https=) | ||
| JP2007500158A5 (https=) | ||
| JP2007519701A5 (https=) |